Evidence map›Paper›PMID 26120211›Full record

ArticleTetrahedron letters2015

Synthesis and bioactivity of MSH4 oligomers prepared by an A

Dilani Chathurika Dehigaspitiya, Suryakiran Navath, Craig S Weber, Ronald M Lynch, Eugene A Mash

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tetrahedron letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dilani Chathurika DehigaspitiyaDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041, USA.
Suryakiran NavathDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041, USA.
Craig S WeberDepartment of Physiology, University of Arizona, Tucson, AZ 85724-5051, USA.
Ronald M LynchDepartment of Physiology, University of Arizona, Tucson, AZ 85724-5051, USA ; The Bio5 Institute, University of Arizona, Tucson, AZ 85721-0240, USA.
Eugene A MashDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041, USA.
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Multimeric Ligands for Targeting of MelanomaR01CA097360 · NCI · UNIVERSITY OF ARIZONA · PI HRUBY, VICTOR J, MORSE, DAVID L · 2003 to 2012
$5.5M
Targeting Pancreatic CancerR01CA123547 · NCI · UNIVERSITY OF ARIZONA · PI MORSE, DAVID L · 2007 to 2011
$3.0M
Multimeric Ligands for Targeting of Pancreatic CancerR33CA095944 · NCI · UNIVERSITY OF ARIZONA · PI GILLIES, ROBERT J. · 2003 to 2005
$1.6M
NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA097360NCI NIH HHS R01 CA123547NCI NIH HHS R33 CA095944
6 · The paper itself

Abstract

Oligomers incorporating the tetrapeptide MSH4, the minimum active sequence of melanocyte stimulating hormone, were synthesized by an A

Indexed as

Competitive binding assayMelanocortin 4 receptorMultivalent ligandOligomerizationTime-resolved fluorescence

Identifiers

PMID26120211
PMCPMC4480789
OpenAlexW1995683145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.